[18F]FDOPA PET/CT in Solid Pseudopapillary Tumor of the Pancreas: a Recurred Tumor Mimicking Splenosis
Nuclear Medicine and Molecular Imaging - Trang 1-5 - 2023
Tóm tắt
Solid pseudopapillary tumor (SPT) of the pancreas is a neoplasm with low malignant potential. It is often challenging to diagnose SPT due to its nonspecific clinical and radiological features, and [18F]FDOPA is effective in diagnosing SPT, particularly in differentiating SPT from benign conditions such as splenosis. A 55-year-old woman underwent distal pancreatectomy and splenectomy for histologically confirmed SPT. She was also initially diagnosed with splenosis. During follow-up, sizes of multiple nodular lesions were increased, raising the possibility of peritoneal seeding of SPT. For diagnosis, a spleen scan and SPECT/CT were performed using 99mTc-labeled damaged red blood cells, which showed no uptake in the peritoneal nodules. Subsequent [18F]FDOPA PET/CT revealed [18F]FDOPA-avidity of the nodules. The patient underwent tumor resection surgery, and the nodules were pathologically confirmed as SPT.
Tài liệu tham khảo
Guo N, Zhou QB, Chen RF, Zou SQ, Li ZH, Lin Q, et al. Diagnosis and surgical treatment of solid pseudopapillary neoplasm of the pancreas: analysis of 24 cases. Can J Surg. 2011;54:368–74.
Lüttges J. Was ist neu? Pathol. 2011;32:332.
Lam KY, Lo CY, Fan ST. Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg. 1999;23:1045–50.
Mazzarella G, Muttillo EM, Coletta D, Picardi B, Rossi S, Rossi Del Monte S, et al. Solid pseudopapillary tumor of the pancreas: a systematic review of clinical, surgical and oncological characteristics of 1384 patients underwent pancreatic surgery. Hepatobiliary Pancreat Dis Int. 2023. https://doi.org/10.1016/j.hbpd.2023.05.004
Coelho JCU, Costa MAR da, Ramos EJB, Torres AR, Savio MC, Claus CMP. Surgical management of solid pseudopapillary tumor of the pancreas. JSLS. 2018;22(4):e2018.00032. https://doi.org/10.4293/JSLS.2018.00032.
Kiroff GK. Splenosis following splenectomy. Arch Surg. 1984;119:351.
Vernuccio F, Dimarco M, Porrello G, Cannella R, Cusmà S, Midiri M, et al. Abdominal splenosis and its differential diagnoses: what the radiologist needs to know. Curr Probl Diagn Radiol. 2021;50:229–35.
Santhanam P, Taïeb D. Role of 18F-FDOPA PET/CT imaging in endocrinology. Clin Endocrinol (Oxf). 2014;81:789–98.
Chen W, Silverman DHS, Delaloye S, Czernin J, Kamdar N, Pope W, et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904–11.
Darcourt J, Schiazza A, Sapin N, Dufour M, Ouvrier MJ, Benisvy D, et al. 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q J Nucl Med Mol Imaging. 2014;58:355–65.
Koopmans KP, Neels ON, Kema IP, Elsinga PH, Links TP, de Vries EGE, et al. Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results. Crit Rev Oncol Hematol. 2009;71:199–213.
Minn H, Kauhanen S, Seppänen M, Nuutila P. 18F-FDOPA: a multiple-target molecule. J Nucl Med. 2009;50:1915–8.
Chondrogiannis S, Cristina Marzola M, Al-Nahhas A, Venkatanarayana TD, Mazza A, Opocher G, et al. Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging. Nucl Med Commun. 2013;34:1141–9.
Chondrogiannis S, Grassetto G, Marzola MC, Rampin L, Massaro A, Bellan E, et al. 18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours. Nucl Med Commun. 2012;33:179.
Imperiale A, Addeo P, Averous G, Namer IJ, Bachellier P. Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on 18F-FDOPA PET/CT. J Clin Endocrinol Metab. 2013;98:2643–4.
Somme F, Montaz-Rosset M-S, Averous G, Deur J, Goichot B, Bachellier P, et al. Solid pseudopapillary tumour should be part of differential diagnosis of focal pancreatic lesions with increased 18F-FDOPA uptake. Clin Endocrinol (Oxf). 2020;93:78–81.
Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, et al. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol. 2013;111:11–8.
Notohara K, Hamazaki S, Tsukayama C, Nakamoto S, Kawabata K, Mizobuchi K, et al. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol. 2000;24:1361–71.
Berry MD, Juorio AV, Li XM, Boulton AA. Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res. 1996;21:1075–87.
Hiraoka N, Toue S, Okamoto C, Kikuchi S, Ino Y, Yamazaki-Itoh R, et al. Tissue amino acid profiles are characteristic of tumor type, malignant phenotype, and tumor progression in pancreatic tumors. Sci Rep. 2019;9:9816.
Lu J, Li P, Yang Y, Wang L, Zhang Y, Zhu J, et al. Prognostic value of LAT-1 status in solid cancer: a systematic review and meta-analysis. PLoS One. 2020;15: e0233629.
McGivan JD, Pastor-Anglada M. Regulatory and molecular aspects of mammalian amino acid transport. Biochem J. 1994;299:321–34.
Fremont RD, Rice TW. Splenosis: a review. South Med J. 2007;100(6):589–93.
Tandon YK, Coppa CP, Purysko AS. Splenosis: a great mimicker of neoplastic disease. Abdom Radiol. 2018;43:3054–9.
Lin W-C, Lee R-C, Chiang J-H, Wei C-J, Chu L-S, Liu R-S, et al. MR features of abdominal splenosis. Am J Roentgenol. 2003;180:493–6.
Lake ST, Johnson PT, Kawamoto S, Hruban RH, Fishman EK. CT of splenosis: patterns and pitfalls. Am J Roentgenol. 2012;199:W686-93.